Literature DB >> 23715652

Impact of body mass index on postoperative outcome of advanced gastric cancer after curative surgery.

Yen-Shu Lin1, Kuo-Hung Huang, Yuan-Tzu Lan, Wen-Liang Fang, Jen-Hao Chen, Su-Shun Lo, Mao-Chih Hsieh, Anna Fen-Yau Li, Shih-Hwa Chiou, Chew-Wun Wu.   

Abstract

INTRODUCTION: The impact of body mass index (BMI) on the outcome of advanced gastric cancer surgery is controversial. Between December 1987 and December 2006, a total of 947 advanced gastric cancer patients receiving curative resection with retrieved lymph node number >15 were studied and divided into three groups according to BMI (<25, 25-30, and >30 kg/m(2)). RESULTS AND DISCUSSION: With regard to comorbidities present prior to surgery, higher BMI patients were more likely to have heart disease, type 2 diabetes, and hypertension than lower BMI patients. Compared with BMI <25 kg/m(2), higher BMI patients had longer operative time and more surgery-related morbidity. Multivariate Cox proportional-hazard analysis showed that age, pathological T and N categories, and lymphovascular invasion were independent prognostic factors. The initial recurrence patterns, 5-year overall survival, and cancer-specific survival were similar among the three groups.
CONCLUSION: Only in stage III gastric cancer with BMI less than 25 kg/m(2) patients receiving total gastrectomy had a more advanced pathological N category and a worse prognosis compared to those receiving subtotal gastrectomy. Higher BMI was associated with longer operative time and more surgery-related morbidity than lower BMI. BMI alone is not an independent prognostic factor.

Entities:  

Mesh:

Year:  2013        PMID: 23715652     DOI: 10.1007/s11605-013-2238-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  27 in total

1.  Effect of fat volume on postoperative complications and survival rate after D2 dissection for gastric cancer.

Authors:  Satoshi Inagawa; Shinya Adachi; Tatsuya Oda; Toru Kawamoto; Naoto Koike; Katashi Fukao
Journal:  Gastric Cancer       Date:  2000-12-27       Impact factor: 7.370

2.  Implications of overweight in gastric cancer: A multicenter study in a Western patient population.

Authors:  J Kulig; M Sierzega; P Kolodziejczyk; J Dadan; M Drews; M Fraczek; A Jeziorski; M Krawczyk; T Starzynska; G Wallner
Journal:  Eur J Surg Oncol       Date:  2010-08-21       Impact factor: 4.424

3.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

4.  Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501).

Authors:  Toshimasa Tsujinaka; Mitsuru Sasako; Seiichiro Yamamoto; Takeshi Sano; Yukinori Kurokawa; Atsushi Nashimoto; Akira Kurita; Hitoshi Katai; Toshio Shimizu; Hiroshi Furukawa; Satoru Inoue; Masahiro Hiratsuka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura
Journal:  Ann Surg Oncol       Date:  2006-12-05       Impact factor: 5.344

5.  Risk factors for para-aortic lymph node metastasis of gastric cancer from a randomized controlled trial of JCOG9501.

Authors:  Eiji Nomura; Mitsuru Sasako; Seiichiro Yamamoto; Takeshi Sano; Toshimasa Tsujinaka; Taira Kinoshita; Hiroshi Furukawa; Toshio Shimizu; Masahiro Hiratsuka; Osamu Kobayashi; Yukinori Kurokawa; Nobuhiko Tanigawa
Journal:  Jpn J Clin Oncol       Date:  2007-06       Impact factor: 3.019

6.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

7.  Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients.

Authors:  J J Bonenkamp; I Songun; J Hermans; M Sasako; K Welvaart; J T Plukker; P van Elk; H Obertop; D J Gouma; C W Taat
Journal:  Lancet       Date:  1995-03-25       Impact factor: 79.321

8.  Proximal versus distal gastric carcinoma--what are the differences?

Authors:  P Piso; U Werner; H Lang; P Mirena; J Klempnauer
Journal:  Ann Surg Oncol       Date:  2000-08       Impact factor: 5.344

9.  Analysis of gallbladder bile in morbid obesity.

Authors:  J B Freeman; P D Meyer; K J Printen; E E Mason; L DenBesten
Journal:  Am J Surg       Date:  1975-02       Impact factor: 2.565

Review 10.  Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies.

Authors:  Ping Yang; Yong Zhou; Bo Chen; Hong-Wei Wan; Gui-Qing Jia; Hai-Long Bai; Xiao-Ting Wu
Journal:  Eur J Cancer       Date:  2009-05-06       Impact factor: 9.162

View more
  13 in total

1.  Body mass index and mortality in patients with gastric cancer: a large cohort study.

Authors:  Jung Hwan Lee; Boram Park; Jungnam Joo; Myeong-Cherl Kook; Young-Il Kim; Jong Yeul Lee; Chan Gyoo Kim; Il Ju Choi; Bang Wool Eom; Hong Man Yoon; Keun Won Ryu; Young-Woo Kim; Soo-Jeong Cho
Journal:  Gastric Cancer       Date:  2018-04-12       Impact factor: 7.370

2.  Race/Ethnicity is predictive of lymph node status in patients with early gastric cancer.

Authors:  Shinichi Fukuhara; Mariko Yabe; Marissa M Montgomery; Shinobu Itagaki; Steven T Brower; Martin S Karpeh
Journal:  J Gastrointest Surg       Date:  2014-07-25       Impact factor: 3.452

3.  Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience.

Authors:  Joyce Wong; Shams Rahman; Nadia Saeed; Hui-Yi Lin; Khaldoun Almhanna; Ravi Shridhar; Sarah Hoffe; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2014-01-18       Impact factor: 3.452

4.  Overweight or Obesity is an Unfavorable Long-Term Prognostic Factor for Patients who Underwent Gastrectomy for Stage II/III Gastric Cancer.

Authors:  Yuichi Kambara; Norihiro Yuasa; Eiji Takeuchi; Hideo Miyake; Hidemasa Nagai; Yuichiro Yoshioka; Masataka Okuno; Kanji Miyata
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

5.  Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Completion of Perioperative Adjuvant Chemotherapy May Be a Confounding Factor.

Authors:  Wei Peng; Jing Dai; Chao-Chan Liu; Dian Liu; Hua Xiao
Journal:  Front Oncol       Date:  2022-06-13       Impact factor: 5.738

6.  Morbidity and short-term surgical outcomes of robotic versus laparoscopic distal gastrectomy for gastric cancer: a large cohort study.

Authors:  Li Zheng-Yan; Zhao Yong-Liang; Qian Feng; Shi Yan; Yu Pei-Wu
Journal:  Surg Endosc       Date:  2020-07-20       Impact factor: 4.584

7.  Incidence and risk factors of postoperative complications after robotic gastrectomy for gastric cancer: an analysis of 817 cases based on 10-year experience in a large-scale center.

Authors:  Zheng-Yan Li; Yong-Liang Zhao; Feng Qian; Bo Tang; Jun Chen; Fan Zhang; Ping-Ang Li; Zi-Yan Luo; Yan Shi; Pei-Wu Yu
Journal:  Surg Endosc       Date:  2021-01-25       Impact factor: 4.584

8.  Comparison of Survival Rates, Tumor Stages, and Localization in between Obese and Nonobese Patients with Gastric Cancer.

Authors:  Hakan Kocoglu; Hakan Dogan; Basak Oguz; Sibel Ocak Serin; Yildiz Okuturlar; Meral Gunaldi; Betul Erismis; Bahar Ozdemir; Deniz Tural; Mehmet Hursitoglu; Ozlem Harmankaya; Abdulbaki Kumbasar
Journal:  Gastroenterol Res Pract       Date:  2016-06-21       Impact factor: 2.260

9.  Clinical and Oncological Value of Preoperative BMI in Gastric Cancer Patients: A Single Center Experience.

Authors:  Costantino Voglino; Giulio Di Mare; Francesco Ferrara; Lorenzo De Franco; Franco Roviello; Daniele Marrelli
Journal:  Gastroenterol Res Pract       Date:  2015-02-10       Impact factor: 2.260

10.  The Impact of Body Mass Index on the Surgical Outcomes of Patients With Gastric Cancer: A 10-Year, Single-Institution Cohort Study.

Authors:  Hai-Ning Chen; Xin-Zu Chen; Wei-Han Zhang; Kun Yang; Xiao-Long Chen; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.